A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
AstraZeneca
Mayo Clinic
Aminex Therapeutics, Inc.
Hummingbird Bioscience
Essen Biotech
Essen Biotech
Sapience Therapeutics
M.D. Anderson Cancer Center
Second Life Therapeutics
Onchilles Pharma Inc
Transgene
Strand Therapeutics Inc.
Hadassah Medical Organization
Hadassah Medical Organization
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Incyte Corporation
Cancer Research UK
MacroGenics
NuCana plc
Medicenna Therapeutics, Inc.
OncoC4, Inc.
Kymab Limited
BioAtla, Inc.
Aminex Therapeutics, Inc.
Universitair Ziekenhuis Brussel
National Cancer Institute (NCI)
Simcha IL-18, Inc.
Salubris Biotherapeutics Inc
NGM Biopharmaceuticals, Inc
Pfizer
Innolake Biopharm
GeneMedicine Co., Ltd.
NextCure, Inc.
Kineta Inc.
Nektar Therapeutics
Nektar Therapeutics
Rubius Therapeutics
Ludwig Institute for Cancer Research
Incyte Corporation
Novartis
Philogen S.p.A.
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Novartis
Incyte Corporation
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)